Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Long-Term Investments (2020 - 2023)

Rapid Micro Biosystems' Long-Term Investments history spans 4 years, with the latest figure at $2.9 million for Q4 2023.

  • For Q4 2023, Long-Term Investments fell 90.23% year-over-year to $2.9 million; the TTM value through Dec 2023 reached $2.9 million, down 90.23%, while the annual FY2023 figure was $2.9 million, 90.23% down from the prior year.
  • Long-Term Investments for Q4 2023 was $2.9 million at Rapid Micro Biosystems, down from $14.6 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $35.2 million in Q3 2022 and bottomed at $695000.0 in Q4 2020.
  • The 4-year median for Long-Term Investments is $12.3 million (2021), against an average of $14.2 million.
  • The largest annual shift saw Long-Term Investments soared 2512.31% in 2022 before it crashed 90.23% in 2023.
  • A 4-year view of Long-Term Investments shows it stood at $695000.0 in 2020, then surged by 1333.96% to $10.0 million in 2021, then soared by 198.92% to $29.8 million in 2022, then plummeted by 90.23% to $2.9 million in 2023.
  • Per Business Quant, the three most recent readings for RPID's Long-Term Investments are $2.9 million (Q4 2023), $14.6 million (Q3 2023), and $7.2 million (Q2 2023).